Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 137

Sort by

Sort Order Select

Journal Articles

Editor’s Note: PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR

Cancer Res (2025) 85 (5): 1003.

https://doi.org/10.1158/0008-5472.CAN-24-5044

Published: 03 March 2025

View articletitled, Editor’s Note: PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR

Journal Articles

Abstract 2690: In vivo CRISPR screen identifies SOAT1 as a chemotherapy chemosensitizing target for non-small cell lung cancer (NSCLC)

Long Shan Li, Kenneth Huffman, Huiyu Li, Michael Peyton, Hyunsil Park, Kimberley Avila, Luc Girard, Mathew Augustine, Joshua T. Mendell, John D. Minna

Cancer Res (2023) 83 (7_Supplement): 2690.

https://doi.org/10.1158/1538-7445.AM2023-2690

Published: 04 April 2023

View articletitled, Abstract 2690: In vivo CRISPR screen identifies SOAT1 as a chemotherapy chemosensitizing target for non-small cell lung cancer (NSCLC)

Journal Articles

Abstract 3245: AXL as a therapeutic target in STK11 mutant NSCLC

Magnus Blø, Austin Rayford, Noëlly Madeleine, Fabian Gärtner, Dana Bohan, Natalie Ruggio, Huiyu Li, Luc Girard, Rolf Brekken, John Minna, Marianne Ånerud, Wendy Maury, Claudia Gorcea-Carson, Gro Gausdal, David R. Micklem, Nigel McCracken

Cancer Res (2023) 83 (7_Supplement): 3245.

https://doi.org/10.1158/1538-7445.AM2023-3245

Published: 04 April 2023

View articletitled, Abstract 3245: AXL as a therapeutic target in STK11 mutant NSCLC

Journal Articles

Abstract 6572: A lung cancer cell line explorer

Ling Cai, Luc Girard, Ralph DeBerardinis, Guanghua Xiao, John Minna, Yang Xie

Cancer Res (2023) 83 (7_Supplement): 6572.

https://doi.org/10.1158/1538-7445.AM2023-6572

Published: 04 April 2023

View articletitled, Abstract 6572: A lung cancer cell line explorer

Journal Articles

Abstract 702: Single-cell expression landscape of SARS-CoV-2 receptor ACE2 and host proteases in human lung adenocarcinoma

Cancer Res (2021) 81 (13_Supplement): 702.

https://doi.org/10.1158/1538-7445.AM2021-702

Published: 01 July 2021

View articletitled, Abstract 702: Single-cell expression landscape of SARS-CoV-2 receptor ACE2 and host proteases in human lung adenocarcinoma

Journal Articles

Abstract 203: SCLC-CellMiner: An extensive cell line genomic and pharmacology resource identifies a subgroup of small cell lung cancers sensitive to targeted therapies and immunotherapies

Cancer Res (2021) 81 (13_Supplement): 203.

https://doi.org/10.1158/1538-7445.AM2021-203

Published: 01 July 2021

View articletitled, Abstract 203: SCLC-CellMiner: An extensive cell line genomic and pharmacology resource identifies a subgroup of small cell lung cancers sensitive to targeted therapies and immunotherapies

Journal Articles

Abstract 1906: Relationship between neuroendocrine and immune gene expression in small cell lung cancer

Ling Cai, Hongyu Liu, Fang Huang, Junya Fujimoto, Luc Girard, Yang Xie, John Minna, Adi Gazdar

Cancer Res (2021) 81 (13_Supplement): 1906.

https://doi.org/10.1158/1538-7445.AM2021-1906

Published: 01 July 2021

View articletitled, Abstract 1906: Relationship between neuroendocrine and immune gene expression in small cell lung cancer

Journal Articles

Evasion of Innate Immunity Contributes to Small Cell Lung Cancer Progression and Metastasis

Mingrui Zhu, Yi Huang, Matthew E. Bender, Luc Girard, Rahul Kollipara, Buse Eglenen-Polat, Yujiro Naito, Trisha K. Savage, Kenneth E. Huffman, Shohei Koyama, Atsushi Kumanogoh, John D. Minna, Jane E. Johnson, Esra A. Akbay

Cancer Res (2021) 81 (7): 1813–1826.

https://doi.org/10.1158/0008-5472.CAN-20-2808

Published: 01 April 2021

View articletitled, Evasion of Innate Immunity Contributes to Small Cell Lung Cancer Progression and Metastasis

Includes: Supplementary data

Journal Articles

SLC43A3 Is a Biomarker of Sensitivity to the Telomeric DNA Damage Mediator 6-Thio-2′-Deoxyguanosine

Ilgen Mender, Kimberly Batten, Michael Peyton, Aishwarya Vemula, Crystal Cornelius, Luc Girard, Boning Gao, John D. Minna, Jerry W. Shay

Cancer Res (2020) 80 (5): 929–936.

https://doi.org/10.1158/0008-5472.CAN-19-2257

Published: 02 March 2020

View articletitled, SLC43A3 Is a Biomarker of Sensitivity to the Telomeric DNA Damage Mediator 6-Thio-2′-Deoxyguanosine

Includes: Supplementary data

Journal Articles

Inhibition of Thioredoxin/Thioredoxin Reductase Induces Synthetic Lethality in Lung Cancers with Compromised Glutathione Homeostasis

Xiang Yan, Xiaoshan Zhang, Li Wang, Ran Zhang, Xingxiang Pu, Shuhong Wu, Lei Li, Pan Tong, Jing Wang, Qing H. Meng, Vanessa B. Jensen, Luc Girard, John D. Minna, Jack A. Roth, Stephen G. Swisher, John V. Heymach, Bingliang Fang

Cancer Res (2019) 79 (1): 125–132.

https://doi.org/10.1158/0008-5472.CAN-18-1938

Published: 02 January 2019

View articletitled, Inhibition of Thioredoxin/Thioredoxin Reductase Induces Synthetic Lethality in Lung Cancers with Compromised Glutathione Homeostasis

Includes: Supplementary data

Journal Articles

Abstract 2664: Identification of two small molecules with small cell lung cancer growth inhibition response profiles different from etoposide/topotecan

Allison A. Mootz, Michael Peyton, Paul Yenerall, Kimberley Avila, Kenneth Huffman, Tomohiro Haruki, Mahboubeh Papari-Zareei, Victor Stastny, Luc Girard, Elizabeth McMillan, Michael Roth, John MacMillan, Bruce Posner, Michael White, Gazdar Adi, John Minna

Cancer Res (2018) 78 (13_Supplement): 2664.

https://doi.org/10.1158/1538-7445.AM2018-2664

Published: 01 July 2018

View articletitled, Abstract 2664: Identification of two small molecules with small cell lung cancer growth inhibition response profiles different from etoposide/topotecan

Journal Articles

Abstract 5740: PD-L1 overexpression induced by oncogenic KRAS and BRAF mutations through MAPK pathway activation in non-small cell lung cancer

Yosuke Miura, Noriaki Sunaga, Pinjie Bao, Luc Girard, Yusuke Tsukagoshi, Tomomi Masuda, Norimitsu Kasahara, Reiko Sakurai, Kyoichi Kaira, Takeshi Hisada, John Minna, Masanobu Yamada

Cancer Res (2018) 78 (13_Supplement): 5740.

https://doi.org/10.1158/1538-7445.AM2018-5740

Published: 01 July 2018

View articletitled, Abstract 5740: PD-L1 overexpression induced by oncogenic KRAS and BRAF mutations through MAPK pathway activation in non-small cell lung cancer

Journal Articles

GLI1 Blockade Potentiates the Antitumor Activity of PI3K Antagonists in Lung Squamous Cell Carcinoma

Sahba Kasiri, Chunli Shao, Baozhi Chen, Alexandra N. Wilson, Paul Yenerall, Brenda C. Timmons, Luc Girard, Hui Tian, Carmen Behrens, Ignacio I. Wistuba, Adi F. Gazdar, James Kim

Cancer Res (2017) 77 (16): 4448–4459.

https://doi.org/10.1158/0008-5472.CAN-16-3315

Published: 14 August 2017

View articletitled, GLI1 Blockade Potentiates the Antitumor Activity of PI3K Antagonists in Lung Squamous Cell Carcinoma

Includes: Supplementary data

Journal Articles

Abstract 1111: The chromatin remodelers RUVBL1 and RUVBL2 are prognostic factors and therapeutic targets in non-small cell lung cancer due to their roles in DNA replication, repair, and radiosensitization

Paul Yenerall, Rahul Kollipara, Amit Das, Pamela Villalobos, Long Shan Li, Brenda Timmons, Luc Girard, Jaime Rodriguez-Canales, Ignacio Wistuba, John Minna, Ralf Kittler

Cancer Res (2017) 77 (13_Supplement): 1111.

https://doi.org/10.1158/1538-7445.AM2017-1111

Published: 01 July 2017

View articletitled, Abstract 1111: The chromatin remodelers RUVBL1 and RUVBL2 are prognostic factors and therapeutic targets in non-small cell lung cancer due to their roles in DNA replication, repair, and radiosensitization

Journal Articles

Abstract 3328: Protochadherin 7 acts through SET and PP2A to potentiate MAPK signaling by EGFR and KRAS during lung tumorigenesis

Xiaorong Zhou, Barrett L. Updegraff, Yabin Guo, Michael Peyton, Luc Girard, Jill E. Larsen, Xian-Jin Xie, Yunyun Zhou, Tae Hyun Hwang, Yang Xie, Jaime Rodriguez-Canales, Pamela Villalobos, Carmen Behrens, Wistuba I. Ignacio, John D. Minna, Kathryn A. O'Donnell

Cancer Res (2017) 77 (13_Supplement): 3328.

https://doi.org/10.1158/1538-7445.AM2017-3328

Published: 01 July 2017

View articletitled, Abstract 3328: Protochadherin 7 acts through SET and PP2A to potentiate MAPK signaling by EGFR and KRAS during lung tumorigenesis

Journal Articles

Abstract 2964: Stromal Hedgehog pathway activation suppresses growth and metastases of lung adenocarcinoma

Sahba Kasiri, Baozhi Chen, Alexandra Wilson, Umaru Barrie, Ummay Marriam, Zhiqun Zeng, Luc Girard, James Kim

Cancer Res (2017) 77 (13_Supplement): 2964.

https://doi.org/10.1158/1538-7445.AM2017-2964

Published: 01 July 2017

View articletitled, Abstract 2964: Stromal Hedgehog pathway activation suppresses growth and metastases of lung adenocarcinoma

Journal Articles

PROTOCADHERIN 7 Acts through SET and PP2A to Potentiate MAPK Signaling by EGFR and KRAS during Lung Tumorigenesis

Xiaorong Zhou, Barrett L. Updegraff, Yabin Guo, Michael Peyton, Luc Girard, Jill E. Larsen, Xian-Jin Xie, Yunyun Zhou, Tae Hyun Hwang, Yang Xie, Jaime Rodriguez-Canales, Pamela Villalobos, Carmen Behrens, Ignacio I. Wistuba, John D. Minna, Kathryn A. O'Donnell

Cancer Res (2017) 77 (1): 187–197.

https://doi.org/10.1158/0008-5472.CAN-16-1267-T

Published: 02 January 2017

View articletitled, PROTOCADHERIN 7 Acts through SET and PP2A to Potentiate MAPK Signaling by EGFR and KRAS during Lung Tumorigenesis

Includes: Supplementary data

Journal Articles

Abstract 206: Cytochrome c oxidase subunit 5a (COX5A) is identified as a potential therapeutic target for lung cancer with high therapeutic index through a pooled shRNA screen

Toshio Kato, Mitsuo Sato, Masashi Kondo, Tomohiko Kakumu, Naoyuki Yogo, Tetsunari Hase, Masahiro Morise, Yoshionori Hasegawa, John D. Minnna, Luc Girard

Cancer Res (2016) 76 (14_Supplement): 206.

https://doi.org/10.1158/1538-7445.AM2016-206

Published: 15 July 2016

View articletitled, Abstract 206: Cytochrome c oxidase subunit 5a (COX5A) is identified as a potential therapeutic target for lung cancer with high therapeutic index through a pooled shRNA screen

Journal Articles

Abstract 4028: Oncogenic KRAS mutations induce PD-L1 overexpression through MAPK pathway activation in non-small cell lung cancer cells

Yosuke Miura, Noriaki Sunaga, Kyoichi Kaira, Yusuke Tsukagoshi, Takashi Osaki, Reiko Sakurai, Takeshi Hisada, Luc Girard, John D. Minna, Masanobu Yamada

Cancer Res (2016) 76 (14_Supplement): 4028.

https://doi.org/10.1158/1538-7445.AM2016-4028

Published: 15 July 2016

View articletitled, Abstract 4028: Oncogenic KRAS mutations induce PD-L1 overexpression through MAPK pathway activation in non-small cell lung cancer cells

Journal Articles

Abstract 3017: Non-classical activation of GLI1 as a therapeutic target for squamous cell lung cancer

Sahba Kasiri, Chunli Shao, Baozhi Chen, Alexandra Wilson, Paul Yenerall, Brenda Timmons, patrick dospoy, Suzie Hight, Luc Girard, Hui Tian, Carmen Behrens, Ignacio Wistuba, Adi Gazdar, James Kim

Cancer Res (2016) 76 (14_Supplement): 3017.

https://doi.org/10.1158/1538-7445.AM2016-3017

Published: 15 July 2016

View articletitled, Abstract 3017: Non-classical activation of GLI1 as a therapeutic target for squamous cell lung cancer

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Editor’s Note: PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR

Abstract 2690: In vivo CRISPR screen identifies SOAT1 as a chemotherapy chemosensitizing target for non-small cell lung cancer (NSCLC)

Abstract 3245: AXL as a therapeutic target in STK11 mutant NSCLC

Abstract 6572: A lung cancer cell line explorer

Abstract 702: Single-cell expression landscape of SARS-CoV-2 receptor ACE2 and host proteases in human lung adenocarcinoma

Abstract 203: SCLC-CellMiner: An extensive cell line genomic and pharmacology resource identifies a subgroup of small cell lung cancers sensitive to targeted therapies and immunotherapies

Abstract 1906: Relationship between neuroendocrine and immune gene expression in small cell lung cancer

Evasion of Innate Immunity Contributes to Small Cell Lung Cancer Progression and Metastasis

SLC43A3 Is a Biomarker of Sensitivity to the Telomeric DNA Damage Mediator 6-Thio-2′-Deoxyguanosine

Inhibition of Thioredoxin/Thioredoxin Reductase Induces Synthetic Lethality in Lung Cancers with Compromised Glutathione Homeostasis

Abstract 2664: Identification of two small molecules with small cell lung cancer growth inhibition response profiles different from etoposide/topotecan

Abstract 5740: PD-L1 overexpression induced by oncogenic KRAS and BRAF mutations through MAPK pathway activation in non-small cell lung cancer

GLI1 Blockade Potentiates the Antitumor Activity of PI3K Antagonists in Lung Squamous Cell Carcinoma

Abstract 1111: The chromatin remodelers RUVBL1 and RUVBL2 are prognostic factors and therapeutic targets in non-small cell lung cancer due to their roles in DNA replication, repair, and radiosensitization

Abstract 3328: Protochadherin 7 acts through SET and PP2A to potentiate MAPK signaling by EGFR and KRAS during lung tumorigenesis

Abstract 2964: Stromal Hedgehog pathway activation suppresses growth and metastases of lung adenocarcinoma

PROTOCADHERIN 7 Acts through SET and PP2A to Potentiate MAPK Signaling by EGFR and KRAS during Lung Tumorigenesis

Abstract 206: Cytochrome c oxidase subunit 5a (COX5A) is identified as a potential therapeutic target for lung cancer with high therapeutic index through a pooled shRNA screen

Abstract 4028: Oncogenic KRAS mutations induce PD-L1 overexpression through MAPK pathway activation in non-small cell lung cancer cells

Abstract 3017: Non-classical activation of GLI1 as a therapeutic target for squamous cell lung cancer

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only